Avamere Transitional Care & Rehabilitation – Brighton Opens a Dedicated COVID-19 United

The 50-bed unit at Avamere Transitional Care & Rehabilitation provides a dedicated place for individuals to transition from hospital to home while recovering from the virus, following the recommended 14-day quarantine by the Centers for Disease Control and Prevention.

Avamere Transitional Care & Rehabilitation – Brighton calls this the ABC unit, standing for “Avamere Brighton Cares.”

“Being in the healthcare industry, we have the honor of serving seniors in our local community,” stated Rachel Rodriguez, Interim Administrator at Avamere Transitional Care & Rehabilitation – Brighton. “This is our way of helping those who need us most during this crucial time.”

The unit will feature dedicated full-time occupational, physical, and speech therapists, as well as a unit-dedicated hospice team from Dignity Hospice.

Dr. Shad Grubbs and associate extended providers will work with patients one-on-one in the COVID-19 unit, Avamere’s Medical Director at the Brighton location and Avamere Transitional Care and Rehabilitation – Malley in Northglenn, Colorado.

This dedicated unit is unique for senior care communities in Colorado. In fact, state health officials told Avamere they were a pioneer in Colorado.

But at the heart of it all is a team dedicated to living Avamere’s mission to enhance the life of every person they serve.

“Our altruistic goal is to serve the Denver area, serve the community,” stated Dr. Grubbs.

​Avamere Transitional Care & Rehabilitation – Brighton is accepting patients in Brighton, Colorado, and the surrounding areas.


Other hospital-related news items can be found here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”